5th Annual Spring to Life Conference on Hematologic Malignancies
Speakers
OVERVIEW
5th Annual Spring to Life Conference on Hematologic Malignancies is organized by New York Oncology Hematology (NYOH) and will be held on May 19, 2018 at Albany Marriott, Albany, New York, United States of America.
The target audience for this medical event is hematologists, oncologists, oncology nurses, family and primary care practitioners, allied health professionals, and any other interested cancer care providers. This CME Conference has been approved for a maximum of 3.75 AMA PRA Category 1 Credits.
Spring to Life Conference on Hematologic MalignanciesTM: Conference on Indolent Lymphoid Malignancies is an accredited, educational program developed by New York Oncology Hematology (NYOH), in collaboration with the Center for Emergency Medical Education (CEME), the Leukemia & Lymphoma Society, and a panel of expert faculty from the academic, research, and community practice settings.
With programming for both healthcare professionals and the community, the goal of this 1-day activity is to bring together cancer care providers and members of the community, including patients, survivors, their family, and caregivers, to gain an up-to-date understanding of blood cancers, including ongoing
research, clinical management, and emerging therapies. The program also provides perspectives on the impact of cancer on the lives of patients and families. The 2018 conference will focus on indolent lymphoid malignancies. Specifically, clinician sessions will detail standards of care and current evidence-based and emerging therapeutics, including efficacy, safety, and tolerability, in order to inform a clinical audience on the more common indolent lymphomas and chronic lymphocytic leukemia. The theme of the afternoon patient program is Finding Hope in Times of Transition.
Healthcare professionals are welcome and encouraged to participate in the afternoon patient-centered sessions. You will receive additional information about this program after registering for the conference.
Learning Objectives :
• Identify immunophenotypic and molecular profiling, relevant signaling pathways, and the role of targeted therapies for indolent lymphomas and chronic lymphocytic leukemiac
• Review the current standard of care and therapy options for indolent lymphomas and chronic lymphocytic leukemia
• Evaluate the emerging clinical trial data and immune-oncology approaches to the treatment of indolent lymphomas and chronic lymphocytic leukemia
• Demonstrate the clinical application of this information in the common hematology-oncology practice setting
Additional details will be posted as soon as they are available.
The target audience for this medical event is hematologists, oncologists, oncology nurses, family and primary care practitioners, allied health professionals, and any other interested cancer care providers. This CME Conference has been approved for a maximum of 3.75 AMA PRA Category 1 Credits.
Spring to Life Conference on Hematologic MalignanciesTM: Conference on Indolent Lymphoid Malignancies is an accredited, educational program developed by New York Oncology Hematology (NYOH), in collaboration with the Center for Emergency Medical Education (CEME), the Leukemia & Lymphoma Society, and a panel of expert faculty from the academic, research, and community practice settings.
With programming for both healthcare professionals and the community, the goal of this 1-day activity is to bring together cancer care providers and members of the community, including patients, survivors, their family, and caregivers, to gain an up-to-date understanding of blood cancers, including ongoing
research, clinical management, and emerging therapies. The program also provides perspectives on the impact of cancer on the lives of patients and families. The 2018 conference will focus on indolent lymphoid malignancies. Specifically, clinician sessions will detail standards of care and current evidence-based and emerging therapeutics, including efficacy, safety, and tolerability, in order to inform a clinical audience on the more common indolent lymphomas and chronic lymphocytic leukemia. The theme of the afternoon patient program is Finding Hope in Times of Transition.
Healthcare professionals are welcome and encouraged to participate in the afternoon patient-centered sessions. You will receive additional information about this program after registering for the conference.
Learning Objectives :
• Identify immunophenotypic and molecular profiling, relevant signaling pathways, and the role of targeted therapies for indolent lymphomas and chronic lymphocytic leukemiac
• Review the current standard of care and therapy options for indolent lymphomas and chronic lymphocytic leukemia
• Evaluate the emerging clinical trial data and immune-oncology approaches to the treatment of indolent lymphomas and chronic lymphocytic leukemia
• Demonstrate the clinical application of this information in the common hematology-oncology practice setting
Additional details will be posted as soon as they are available.
KEY DATES
19 May, 2018
Event Start Date
19 May, 2018
Event End Date
SPECIALITIES
Hematology Blood and Marrow TransplantOncologySUGGESTED HOTELS
CONFERENCE VENUE
Albany MarriottRELATED CONFERENCES & LIVE WEBINARS
Quick Links